Market Tracker

12/02 5:16pm ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

1.80
Delayed Data
As of 4:00pm ET
 -0.08 / -4.26%
Today’s Change
1.22
Today|||52-Week Range
2.76
-8.60%
Year-to-Date
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close1.88
Today’s open1.93
Day’s range1.80 - 1.93
Volume228,497
Average volume (3 months)149,623
Market cap$99.3M
Dividend yield217.64%
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-450.00%
Earnings growth (this year)-65.91%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.70

Competitors

 Today’s
change
Today’s
% change
CASCCascadian Therapeuti...+0.53+10.66%
ARWRArrowhead Pharmaceut...+0.12+9.09%
AVXLAnavex Life Sciences...-0.05-1.31%
PBMDPrima BioMed Ltd+0.01+1.19%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$0.00
Annual profit (last year)-$23.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts